Scientific Publications Search Search Author Release Date Research Group Search Sort by RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Order AscDesc Akalin, Altuna Dr. (1) Begay-Müller, Valerie Dr. (1) Birchmeier-Kohler, Carmen Prof. Dr. (1) Chekulaeva, Marina Dr. (2) Daumke, Oliver Prof. Dr. (1) Franke, Vedran Dr. (1) Gotthardt, Michael Prof. Dr. (1) Haucke, Volker Professor (1) Heuser, Arnd Dr. (1) Hinz, Michael Dr. (1) Kempa, Stefan Dr. (1) Kirchner, Marieluise Dr. (1) Ku, Min-Chi Dr. (1) Landthaler, Markus Prof. Dr. (1) Lewin, Gary Prof. Dr. (1) Lusatis, Simone (1) Mathas, Stephan Dr. (8) Müller, Thomas Dr. (1) Niendorf, Thoralf Prof. Dr. (1) Ohler, Uwe Prof. Dr. (2) Poulet, James Prof. Dr. (1) Radke, Michael Dr. (1) Rajewsky, Nikolaus Prof. Dr. (1) Rocks, Oliver Dr. (1) Scheidereit, Claus Prof. Dr. (1) Schmitt, Clemens Prof. Dr. (1) Selbach, Matthias Prof. Dr. (9) Specker, Edgar Dr. (1) Stein, Ulrike Prof. Dr. (1) von Kries, Jens Peter Dr. (1) Walther, Wolfgang Prof. Dr. (1) Woehler, Andrew Dr. (1) Zauber, Henrik Dr. (1) (-) Daniel, Peter Prof. Dr. (1) (-) Janz, Martin Dr. (10) (-) Wollert-Wulf, Brigitte (2) 1999 (1) 2000 (1) 2002 (1) (-) 2003 (3) 2004 (2) 2005 (2) (-) 2006 (4) 2007 (2) 2008 (2) 2009 (3) 2010 (1) 2011 (4) 2012 (2) 2013 (2) 2014 (2) 2015 (2) 2016 (1) (-) 2017 (3) 2018 (1) 2020 (4) 2021 (3) 2022 (4) 2023 (6) 2024 (1) (-) Biology of Malignant Lymphomas (10) Genetics and Genomics of Cardiovascular Diseases (2) Integrative Vascular Biology (1) Molecular Immunology and Gene Therapy (16) Translational Bioinformatics (1) Translational Oncology of Solid Tumors (4) 10 Results: Active Filter: Daniel, Peter Prof. Dr.Janz, Martin Dr.Wollert-Wulf, BrigitteBiology of Malignant Lymphomas200320062017 Sort: Result score Newest to oldest Oldest to newest January 01, 2003 / J Biol Chem YB-1 as a cell cycle-regulated transcription factor facilitating cyclin A and cyclin B1 gene expression K. Juerchott S. Bergmann U. Stein W. Walther M. Janz I. Manni G. Piaggio E. Fietze M. Dietel H.D. Royer August 01, 2003 / Blood Inhibition of NF-κB essentially contributes to arsenic-induced apoptosis S. Mathas A. Lietz M. Janz M. Hinz F. Jundt C. Scheidereit K. Bommert B. Doerken May 15, 2006 / Cell Cycle Reprogramming of B lymphoid cells in human lymphoma pathogenesis M. Janz B. Doerken S. Mathas March 15, 2006 / Blood Classical Hodgkin lymphoma is characterized by high constitutive expression of activating transcription factor 3 (ATF3) which promotes viability of Hodgkin/Reed-Sternberg cells M. Janz M. Hummel M. Truss B. Wollert-Wulf S. Mathas K. Joehrens C. Hagemeier K. Bommert H. Stein B. Doerken R.C. Bargou April 01, 2006 / Cell Death Differ Loss of the tissue-specific proapoptotic BH3-only protein Nbk/Bik is a unifying feature of renal cell carcinoma I. Sturm C. Stephan B. Gillissen R. Siebert M. Janz S. Radetzki K. Jung S. Loening B. Doerken P.T. Daniel February 01, 2006 / Nat Immunol Intrinsic inhibition of transcription factor E2A by HLH proteins ABF-1 and Id2 mediates reprogramming of neoplastic B cells in Hodgkin lymphoma S. Mathas M. Janz F. Hummel M. Hummel B. Wollert-Wulf S. Lusatis I. Anagnostopoulos A. Lietz M. Sigvardsson F. Jundt K. Joehrens K. Bommert H. Stein B. Doerken May 01, 2003 / Blood Macrophage inflammatory protein 1-alpha (MIP-1alpha) triggers migration and signaling cascades mediating survival and proliferation in multiple myeloma (MM) cells S. Lentzsch M. Gries M. Janz R. Bargou B. Doerken M.Y. Mapara April 01, 2017 / Br J Haematol Subsequent malignancies among long-term survivors of Hodgkin lymphoma and non-Hodgkin lymphoma: a pooled analysis of German cancer registry data (1990-2012) N. Baras S. Dahm J. Haberland M. Janz K. Emrich K. Kraywinkel A. Salama December 13, 2017 / J Neurosci Graded elevation of c-Jun in Schwann cells in vivo: gene dosage determines effects on development, remyelination, tumorigenesis, and hypomyelination S.V. Fazal J.A. Gomez-Sanchez L.J. Wagstaff N. Musner G. Otto M. Janz R. Mirsky K.R. Jessen March 01, 2017 / Leukemia Inactivation of the putative ubiquitin-E3 ligase PDLIM2 in classical Hodgkin and anaplastic large cell lymphoma K.D. Wurster F. Hummel J. Richter M. Giefing S. Hartmann M.L. Hansmann S. Kreher K. Köchert D. Krappmann W. Klapper M. Hummel S.S. Wenzel G. Lenz M. Janz B. Dörken R. Siebert S. Mathas
January 01, 2003 / J Biol Chem YB-1 as a cell cycle-regulated transcription factor facilitating cyclin A and cyclin B1 gene expression K. Juerchott S. Bergmann U. Stein W. Walther M. Janz I. Manni G. Piaggio E. Fietze M. Dietel H.D. Royer
August 01, 2003 / Blood Inhibition of NF-κB essentially contributes to arsenic-induced apoptosis S. Mathas A. Lietz M. Janz M. Hinz F. Jundt C. Scheidereit K. Bommert B. Doerken
May 15, 2006 / Cell Cycle Reprogramming of B lymphoid cells in human lymphoma pathogenesis M. Janz B. Doerken S. Mathas
March 15, 2006 / Blood Classical Hodgkin lymphoma is characterized by high constitutive expression of activating transcription factor 3 (ATF3) which promotes viability of Hodgkin/Reed-Sternberg cells M. Janz M. Hummel M. Truss B. Wollert-Wulf S. Mathas K. Joehrens C. Hagemeier K. Bommert H. Stein B. Doerken R.C. Bargou
April 01, 2006 / Cell Death Differ Loss of the tissue-specific proapoptotic BH3-only protein Nbk/Bik is a unifying feature of renal cell carcinoma I. Sturm C. Stephan B. Gillissen R. Siebert M. Janz S. Radetzki K. Jung S. Loening B. Doerken P.T. Daniel
February 01, 2006 / Nat Immunol Intrinsic inhibition of transcription factor E2A by HLH proteins ABF-1 and Id2 mediates reprogramming of neoplastic B cells in Hodgkin lymphoma S. Mathas M. Janz F. Hummel M. Hummel B. Wollert-Wulf S. Lusatis I. Anagnostopoulos A. Lietz M. Sigvardsson F. Jundt K. Joehrens K. Bommert H. Stein B. Doerken
May 01, 2003 / Blood Macrophage inflammatory protein 1-alpha (MIP-1alpha) triggers migration and signaling cascades mediating survival and proliferation in multiple myeloma (MM) cells S. Lentzsch M. Gries M. Janz R. Bargou B. Doerken M.Y. Mapara
April 01, 2017 / Br J Haematol Subsequent malignancies among long-term survivors of Hodgkin lymphoma and non-Hodgkin lymphoma: a pooled analysis of German cancer registry data (1990-2012) N. Baras S. Dahm J. Haberland M. Janz K. Emrich K. Kraywinkel A. Salama
December 13, 2017 / J Neurosci Graded elevation of c-Jun in Schwann cells in vivo: gene dosage determines effects on development, remyelination, tumorigenesis, and hypomyelination S.V. Fazal J.A. Gomez-Sanchez L.J. Wagstaff N. Musner G. Otto M. Janz R. Mirsky K.R. Jessen
March 01, 2017 / Leukemia Inactivation of the putative ubiquitin-E3 ligase PDLIM2 in classical Hodgkin and anaplastic large cell lymphoma K.D. Wurster F. Hummel J. Richter M. Giefing S. Hartmann M.L. Hansmann S. Kreher K. Köchert D. Krappmann W. Klapper M. Hummel S.S. Wenzel G. Lenz M. Janz B. Dörken R. Siebert S. Mathas